These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5310586)

  • 1. The use of leucovorin orally in normal and leukemic L1210 mice to prevent the toxicity and gastrointestinal lesions caused by high doses of methotrexate.
    Sandberg JS; Goldin A
    Cancer Res; 1970 May; 30(5):1276-80. PubMed ID: 5310586
    [No Abstract]   [Full Text] [Related]  

  • 2. Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium.
    Nederbragt H; Uitendaal MP; van der Grint L; Leyva A; Pinedo HM
    Cancer Res; 1981 Mar; 41(3):1193-8. PubMed ID: 6970074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical use of methotrexate--with emphasis on use of high doses.
    Bertino JR
    Cancer Treat Rep; 1981; 65 Suppl 1():131-5. PubMed ID: 6976829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identical efficacy of methotrexate regimens with N5-methyltetrahydrofolate rescue or with leucovorin rescue for treatment of L1210 murine leukemia.
    Nixon PF; Wilson L
    Cancer Treat Rep; 1983 Jan; 67(1):59-62. PubMed ID: 6604578
    [No Abstract]   [Full Text] [Related]  

  • 5. l-5-formyltetrahydrofolate and l-5-methyltetrahydrofolate rescue in L1210 leukemia treated with high methotrexate doses.
    Simile MM; DeMiglio MR; Nufris A; Pascale RM; Muroni MR; Feo F
    Res Commun Chem Pathol Pharmacol; 1993 Aug; 81(2):251-4. PubMed ID: 8210704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New approaches to chemotherapy with folate antagonists: use of leucovorin "rescue" and enzymic folate depletion.
    Bertino JR; Levitt M; McCullough JL; Chabner B
    Ann N Y Acad Sci; 1971 Nov; 186():486-95. PubMed ID: 4943812
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of the sequence of administration of cytoxan and methotrexate on the life-span of L1210 leukemic mice.
    Straus MJ; Mantel N; Goldin A
    Cancer Res; 1972 Feb; 32(2):200-7. PubMed ID: 5058180
    [No Abstract]   [Full Text] [Related]  

  • 8. Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
    Edelman MJ; Meyers FJ; Houston J; Lauder I
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-68-S15-71. PubMed ID: 9346226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide, methotrexate, and chronic oral tegafur modulated by folinic acid in the treatment of patients with advanced breast carcinoma.
    Ribas A; Albanell J; Solé-Calvo LA; Gallardo E; Bellmunt J; Vera R; Vidal R; Carulla J; Baselga J
    Cancer; 1998 Mar; 82(5):878-85. PubMed ID: 9486577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and therapeutic properties of carrier bound methotrexate against tumor confined to a third space body compartment.
    Chu BC; Howell SB
    J Pharmacol Exp Ther; 1981 Nov; 219(2):389-93. PubMed ID: 6974776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.
    Samuels LL; Straw JA
    Cancer Res; 1984 Jun; 44(6):2278-84. PubMed ID: 6609764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of the therapeutic effectiveness of methotrexate and protection of normal proliferating tissues with purines and pyrimidines.
    Harrap KR; Taylor GA; Browman GP
    Chem Biol Interact; 1977 Jul; 18(1):119-28. PubMed ID: 302148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention by testosterone of the intestinal toxicity caused by the antitumor agent 3-deazauridine.
    Bloch A; Dutschman G; Grindey G; Simpson CL
    Cancer Res; 1974 Jun; 34(6):1299-303. PubMed ID: 4826501
    [No Abstract]   [Full Text] [Related]  

  • 14. Activity of the anthracycline agent, 7-con-O-methylnogarol (7-OMEN), administered orally to mice bearing P388 or L1210 leukemia.
    McGovren JP
    Cancer Treat Rep; 1980; 64(4-5):727-9. PubMed ID: 6448690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of high-dose methotrexate and leucovorin on murine hemopoietic stem cells.
    Pannacciulli I; Massa G; Bogliolo G; Ghio R; Sobrero A
    Cancer Res; 1982 Feb; 42(2):530-4. PubMed ID: 6976827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of benzylpenicillin and doxycycline on toxicity and antineoplastic action of cyclophosphamide and methotrexate in mice].
    Pakulska W
    Acta Pol Pharm; 1992; 49(1-2):35-40. PubMed ID: 8769079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Memorial Sloan Kettering Cancer Center experience with outpatient administration of high dose methotrexate with leucovorin rescue.
    Zelcer S; Kellick M; Wexler LH; Gorlick R; Meyers PA
    Pediatr Blood Cancer; 2008 Jun; 50(6):1176-80. PubMed ID: 18266225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral administration of anti-doxorubicin monoclonal antibody prevents chemotherapy-induced gastrointestinal toxicity in mice.
    Morelli D; Ménard S; Colnaghi MI; Balsari A
    Cancer Res; 1996 May; 56(9):2082-5. PubMed ID: 8616854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxicity of adriamycin combined with methotrexate against L1210 leukemia in mice.
    Valeriote F; Vietti T; Coulter D
    J Natl Cancer Inst; 1980 Apr; 64(4):801-5. PubMed ID: 6928994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of priming dose schedules in methotrexate treatment of mouse leukemia L1210.
    Straus MJ; Mantel N; Goldin A
    Cancer Res; 1971 Oct; 31(10):1429-33. PubMed ID: 5095131
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.